Author

Marianna Kruithof-de Julio

University of BernORCID 0000-0002-6693-8515Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Christian PloneriD· 1 shared Daniel Johannes StekhoveniD· 1 shared Edward E. BrunneriD· 1 shared Elai DavicioniiD· 1 shared Elisabeth DamischiD· 1 shared Ewan A. GibbiD· 1 shared Francesco BaschieriiD· 1 shared Francesco BonolloiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Christian PlonerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedDec 1, 2025

Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts

Edward E. Brunner, Elisabeth Damisch, Melanie Emma Groninger…·Natalie Sampson

This study identifies the YAP1-TGFβ1 axis as a driver of androgen receptor loss in prostate cancer-associated fibroblasts, showing its role in promoting aggressive disease and resistance to therapy.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMay 22, 2020

Personalized in-silico drug response prediction based on the genetic landscape of muscle-invasive bladder cancer

Friedemann Krentel, Franziska Singer, María L. Rosano-González…·Roland Seiler

The paper presents an automated workflow for in-silico drug response prediction in bladder cancer using multi-omic profiles, identifying personalized treatment options for most patients.

DOI 10.1101/2020.05.22.101428

humanbulk RNA-seq

𝕏 PostBluesky